Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection von Alhamad, T., Venkatachalam, K., Linette, G. P., Brennan, D. C.

Volltext

1181 Health-related quality of life in patients with malignant melanoma by stage and treatment status von Rosenberg, A.R., Cornelius, L.A., Weston, S.J., Deshields, T.L., Fields, R.C., Linette, G.P., Semenov, Y.R.

Volltext

Extensive tumoral melanosis associated with ipilimumab‐treated melanoma von Staser, K., Chen, D., Solus, J., Rosman, I.S., Schaffer, A., Cornelius, L., Linette, G.P., Fields, R.C.

Volltext

Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up von D'Angelo, S.P., Bhatia, S., Brohl, A.S., Hamid, O., Mehnert, J.M., Terheyden, P., Shih, K.C., Brownell, I., Lebbé, C., Lewis, K.D., Linette, G.P., Milella, M., Xiong, H., Guezel, G., Nghiem, P.T.

Volltext

603 Handheld dual-modality ultrasound and photoacoustic imaging for in vivo determination of melanoma depth von Tripathi, S.V., Zhou, Y., Linette, G.P., Rosman, I.S., Council, M., Fields, R.C., Wang, L.V., Cornelius, L.

Volltext

23LBA BEAM: A randomized phase II study evaluating the activity of BEvacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated Advanced Melano... von O'Day, S.J, Kim, K.B, Sosman, J.A, Peterson, A.C, Feng, S, Minor, D.R, Fruehauf, J.P, Linette, G.P, Markovic, S.N, Carson, W.E

Volltext

Induction of anti‐HIV neutralizing antibodies by synthetic peptides von Chanh, T.C., Dreesman, G.R., Kanda, P., Linette, G.P., Sparrow, J.T., Ho, D.D., Kennedy, R.C.

Volltext

Extensive tumoral melanosis associated with ipilimumab-treated melanoma von Staser, K., Chen, D., Solus, J., Rosman, I.S., Schaffer, A., Cornelius, L., Linette, G.P., Fields, R.C.

Volltext